Accelerate Diagnostics, Inc.

DB:1A80 Stock Report

Market Cap: €18.2m

Accelerate Diagnostics Past Earnings Performance

Past criteria checks 0/6

Accelerate Diagnostics has been growing earnings at an average annual rate of 7.1%, while the Medical Equipment industry saw earnings growing at 2% annually. Revenues have been growing at an average rate of 9.3% per year.

Key information

7.1%

Earnings growth rate

21.6%

EPS growth rate

Medical Equipment Industry Growth4.3%
Revenue growth rate9.3%
Return on equityn/a
Net Margin-507.8%
Last Earnings Update31 Mar 2024

Recent past performance updates

Recent updates

Revenue & Expenses Breakdown
Beta

How Accelerate Diagnostics makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

DB:1A80 Revenue, expenses and earnings (USD Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
31 Mar 2412-622724
31 Dec 2312-623125
30 Sep 2312-633426
30 Jun 2312-803526
31 Mar 2313-663928
31 Dec 2213-623927
30 Sep 2213-714225
30 Jun 2213-644423
31 Mar 2212-674621
31 Dec 2112-784922
30 Sep 2112-744922
30 Jun 2112-844923
31 Mar 2111-814822
31 Dec 2011-784721
30 Sep 2012-814922
30 Jun 2010-825123
31 Mar 2010-845224
31 Dec 199-845225
30 Sep 198-855226
30 Jun 197-875128
31 Mar 197-895428
31 Dec 186-885528
30 Sep 186-825327
30 Jun 185-775325
31 Mar 184-714925
31 Dec 174-644522
30 Sep 172-644422
30 Jun 171-644223
31 Mar 171-654026
31 Dec 160-663730
30 Sep 160-633331
30 Jun 160-572729
31 Mar 160-522328
31 Dec 150-451927
30 Sep 150-411525
30 Jun 150-391324
31 Mar 150-351222
31 Dec 140-311120
30 Sep 140-271018
30 Jun 140-22814
31 Mar 140-18612
31 Dec 130-15411
30 Sep 130-13311
30 Jun 130-1348

Quality Earnings: 1A80 is currently unprofitable.

Growing Profit Margin: 1A80 is currently unprofitable.


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: 1A80 is unprofitable, but has reduced losses over the past 5 years at a rate of 7.1% per year.

Accelerating Growth: Unable to compare 1A80's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: 1A80 is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (-2.8%).


Return on Equity

High ROE: 1A80's liabilities exceed its assets, so it is difficult to calculate its Return on Equity.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.